Edition:
India

Aytu BioScience Inc (AYTU.OQ)

AYTU.OQ on NASDAQ Stock Exchange Capital Market

1.35USD
20 Sep 2019
Change (% chg)

$-0.06 (-4.26%)
Prev Close
$1.41
Open
$1.42
Day's High
$1.43
Day's Low
$1.35
Volume
37,893
Avg. Vol
42,885
52-wk High
$4.80
52-wk Low
$0.69

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.44 June 21 Sep 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.00 1.00 1.00 1.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 2 2.04 2.07 2.00 --
Quarter Ending Jun-19 2 1.77 1.85 1.70 --
Year Ending Jun-19 2 7.38 7.45 7.30 --
Year Ending Jun-20 2 12.99 13.49 12.50 --
Earnings (per share)
Quarter Ending Mar-19 2 -0.44 -0.34 -0.55 --
Quarter Ending Jun-19 2 -0.38 -0.34 -0.41 --
Year Ending Jun-19 2 -2.35 -2.33 -2.37 --
Year Ending Jun-20 2 -1.03 -0.87 -1.19 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 2.04 2.38 0.34 16.86
Quarter Ending Dec-18 1.69 1.79 0.10 6.06
Quarter Ending Sep-18 1.33 1.43 0.11 8.06
Quarter Ending Mar-18 1.25 0.61 0.64 51.40
Quarter Ending Dec-17 1.30 1.05 0.25 19.14

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 2.04 -- -- -- --
Quarter Ending Jun-19 1.77 1.77 1.77 1.77 --
Year Ending Jun-19 7.38 7.38 7.38 7.38 --
Year Ending Jun-20 12.99 12.99 12.99 12.99 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 -- -- -- --
Quarter Ending Jun-19 0 0 0 0
Year Ending Jun-19 0 0 0 0
Year Ending Jun-20 0 0 0 0
Earnings